Genomic landscape of the DHA1 family in the newly emerged pathogen Candida auris and mapping substrate repertoire of the prominent member CauMdr1
R. Khatoon, S. Sharma, P. Vishwakarma, A. Saini, P. Aggarwal, A. M. Lynn, A. Prakash, R. Prasad, A. Banerjee
Abstract
The last decade has witnessed the rise of extremely threatening healthcare-associated multidrug resistant non-albicans Candida (NAC) species, Candida auris. Thus, understanding the molecular basis of antifungal resistance has emerged as the single most important goal amongst the research community. Since besides target alterations, efflux mechanisms contribute maximally to antifungal resistance, it is imperative to investigate their contributions in this pathogen. Of note, within the Major Facilitator Superfamily (MFS) of efflux pumps, Drug/H+ antiporter family 1 (DHA1) has been established as a predominant contributor towards xenobiotic efflux. Our study provides a complete landscape of DHA1 transporters encoded in the genome of C. auris. This study identifies 14 DHA1 transporters encoded in the genome of the pathogen. We also construct deletion and heterologous overexpression strains for the most important DHA1 drug transporter, viz., CauMdr1 to map the spectrum of its substrates. While the knockout strain did not show any significant changes in the resistance patterns against the majority of the tested substrates, the ortholog when overexpressed in a minimal background S. cerevisiae strain, AD1-8u-, showed significant enhancement in the Minimum inhibitory concentrations (MICs) against a large panel of antifungal molecules. Altogether, the present study provides a comprehensive template for investigating the role of DHA1 members of C. auris in antifungal resistance mechanisms.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genome-wide analysis of experimentally evolved Candida auris reveals multiple novel mechanisms of multidrug-resistance
H. Carolus, S. Pierson, … P. Van Dijck·bioRxiv·Sep 28, 2020
- Construction of a drug sensitised Candida auris strain
Mahnoor Hassan, Jessica Furner-Pardoe, … Barry Panaretou·bioRxiv·Dec 28, 2024
- Broad sensitivity of Candida auris strains to quinolones and mechanisms of resistance
M. B. Lohse, M. T. Laurie, … A. D. Johnson·bioRxiv·Feb 16, 2023
- Coordinated regulation of Mdr1- and Cdr1-mediated protection from antifungals by the Mrr1 transcription factor in emerging Candida spp.
Dhanabala-Subhiksha Rajesh-Khanna, Carolina G. Piña Páez, … Deborah A. Hogan·mBioPeer-reviewed·Oct 7, 2025
- Mutations in TAC1B drive CDR1 and MDR1 expression and azole resistance in C. auris
Katherine S. Barker, Darian J. Santana, … Phillip David Rogers·bioRxiv·Feb 11, 2025
- What makes Candida auris pan-drug resistant? Integrative insights from genomic, transcriptomic, and phenomic analysis of clinical strains resistant to all four major classes of antifungal drugs
Johanna L. Rhodes, Jonathan L. Jacobs, … Vishnu P. Chaturvedi·Antimicrobial Agents and ChemotherapyPeer-reviewed·Sep 19, 2024